Procedure
Surgical resection of tumor
Surgical resection of tumor is a medical procedure with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_1
1
33%
Ph phase_2
2
67%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (33.3%)
Phase 22 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_2
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
NCT04743310
completedphase_2
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
NCT03165994
completedphase_1
Anti PD-1 Neo-adjuvant Treatment for NSCLC
NCT02938624
Clinical Trials (3)
Showing 3 of 3 trials
NCT04743310Phase 2
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
NCT03165994Phase 2
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
NCT02938624Phase 1
Anti PD-1 Neo-adjuvant Treatment for NSCLC
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3